Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1120860.RAm1DTzrhACWV6vQNj9ugtL2aa4ZoGp3WEYg39PDCHuB4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1120860.RAm1DTzrhACWV6vQNj9ugtL2aa4ZoGp3WEYg39PDCHuB4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1120860.RAm1DTzrhACWV6vQNj9ugtL2aa4ZoGp3WEYg39PDCHuB4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1120860.RAm1DTzrhACWV6vQNj9ugtL2aa4ZoGp3WEYg39PDCHuB4130_provenance.
- NP1120860.RAm1DTzrhACWV6vQNj9ugtL2aa4ZoGp3WEYg39PDCHuB4130_assertion description "[Since tumor-infiltrating NK and CD4(+) T cells are the main sources of IFN? in tumor lesions, we isolated these cells from peripheral blood of healthy individuals, treated the cells with ovarian cancer OVCAR3 cell-conditioned media, and found a onefold and tenfold increase of IFN? production in NK and CD4(+) T cells, respectively, compared with that in vehicle-treated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1120860.RAm1DTzrhACWV6vQNj9ugtL2aa4ZoGp3WEYg39PDCHuB4130_provenance.
- NP1120860.RAm1DTzrhACWV6vQNj9ugtL2aa4ZoGp3WEYg39PDCHuB4130_assertion evidence source_evidence_literature NP1120860.RAm1DTzrhACWV6vQNj9ugtL2aa4ZoGp3WEYg39PDCHuB4130_provenance.
- NP1120860.RAm1DTzrhACWV6vQNj9ugtL2aa4ZoGp3WEYg39PDCHuB4130_assertion SIO_000772 24141405 NP1120860.RAm1DTzrhACWV6vQNj9ugtL2aa4ZoGp3WEYg39PDCHuB4130_provenance.
- NP1120860.RAm1DTzrhACWV6vQNj9ugtL2aa4ZoGp3WEYg39PDCHuB4130_assertion wasDerivedFrom befree-2016 NP1120860.RAm1DTzrhACWV6vQNj9ugtL2aa4ZoGp3WEYg39PDCHuB4130_provenance.
- NP1120860.RAm1DTzrhACWV6vQNj9ugtL2aa4ZoGp3WEYg39PDCHuB4130_assertion wasGeneratedBy ECO_0000203 NP1120860.RAm1DTzrhACWV6vQNj9ugtL2aa4ZoGp3WEYg39PDCHuB4130_provenance.
- befree-2016 importedOn "2016-02-19" NP1120860.RAm1DTzrhACWV6vQNj9ugtL2aa4ZoGp3WEYg39PDCHuB4130_provenance.